Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atomoxetine Hydrochloride”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03936491
What this trial is testing

The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study

Who this might be right for
Attention Deficit Hyperactivity Disorder
National Taiwan University Hospital 105
Large-scale testing (Phase 3)Study completedNCT00191698
What this trial is testing

Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD

Who this might be right for
Attention Deficit Hyperactivity DisorderOppositional Defiant Disorder
Eli Lilly and Company 226
Testing effectiveness (Phase 2)Study completedNCT00029614
What this trial is testing

Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

Who this might be right for
Substance Use DisordersAttention Deficit Hyperactivity Disorder
University of Pittsburgh 24
Not applicableWithdrawnNCT01741376
What this trial is testing

Progesterone and Atomoxetine for Cocaine Cessation

Who this might be right for
Cocaine DependenceNicotine Dependence
University of Minnesota
Post-approval studies (Phase 4)Study completedNCT00190775
What this trial is testing

A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 502
Post-approval studies (Phase 4)Study completedNCT00607919
What this trial is testing

Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia

Who this might be right for
Attention Deficit Hyperactivity DisorderDyslexia
Eli Lilly and Company 209
Not applicableStudy completedNCT00611533
What this trial is testing

Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women

Who this might be right for
MenopauseCognitive Disturbances
University of Pennsylvania 16
Testing effectiveness (Phase 2)Study completedNCT00174226
What this trial is testing

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Pfizer 241
Not applicableLooking for participantsNCT06232226
What this trial is testing

Attention Deficit Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity DisorderBehavior HyperactiveBehavior Disorders
Nantes University Hospital 80
Post-approval studies (Phase 4)UnknownNCT00252278
What this trial is testing

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Who this might be right for
Attention-Deficit/Hyperactivity Disorder (ADHD)Insomnia
Rhode Island Hospital 36
Not applicableEnded earlyNCT01802515
What this trial is testing

A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment

Who this might be right for
Cocaine DependenceOpiate Dependence
Yale University 14
Post-approval studies (Phase 4)Study completedNCT00866996
What this trial is testing

Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 1,323
Large-scale testing (Phase 3)Study completedNCT00568685
What this trial is testing

Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 153
Large-scale testing (Phase 3)Study completedNCT00557960
What this trial is testing

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Shire 36
Not applicableStudy completedNCT01498549
What this trial is testing

Cognitive Effects of Atomoxetine in Humans: Genetic Moderators

Who this might be right for
Addiction
Yale University 35
Not applicableStudy completedNCT01624649
What this trial is testing

Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

Who this might be right for
Attention-deficit Hyperactivity Disorder
Janssen Korea, Ltd., Korea 289
Large-scale testing (Phase 3)Looking for participantsNCT05159687
What this trial is testing

Study of Atomoxetine in the Prevention of Vasovagal Syncope

Who this might be right for
Vasovagal Syncope
University of Calgary 180
Post-approval studies (Phase 4)Study completedNCT00190879
What this trial is testing

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

Who this might be right for
Attention Deficit Hyperactivity DisorderComorbid Social Anxiety Disorder
Eli Lilly and Company 440
Post-approval studies (Phase 4)UnknownNCT01339286
What this trial is testing

Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Peking University 100
Post-approval studies (Phase 4)Study completedNCT00380692
What this trial is testing

Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder

Who this might be right for
Autistic DisorderAttention Deficit Disorder With Hyperactivity
Eli Lilly and Company 97
Next Page